Clinatec Unveils Cutting-Edge Brain-Computer Neural Interface Technology

When discussing brain-computer interfaces, Elon Musk’s Neuralink isn't the only key player.

Clinatec showcased its innovative research at CES Unveiled during CES 2024. This multidisciplinary research organization focuses on treating neurological diseases and restoring motor functions for individuals affected by brain or spinal injuries.

Located at Polygone Scientifique in Grenoble, France, Clinatec combines the expertise of biologists, nanotechnology specialists, and others. It was established by the research division of France’s CEA, Inserm, and Université Grenoble Alpes.

Clinatec has developed a non-invasive brain implant that rests on the brain's surface to restore electrical communication in damaged areas. According to Abdelmadjid Hihi, Clinatec’s deputy director for scientific affairs and partnerships, “We’ve been working on brain implant technology to utilize brain activity that signals movement intent, assisting those with severe movement impairments.”

For individuals with spinal cord injuries, Clinatec records brain activity using a bio-compatible system equipped with electrodes that transmit signals from the brain. These signals are decoded in real time by machine learning algorithms. “This information is then translated into commands for machines that can help individuals walk, grasp, or hear again," Hihi explained. "We initially tested this system with accident victims."

In a demonstration, a video showed an injured man taking steps with an exoskeleton, driven by signals stimulating both his brain and muscles. Clinatec has successfully worked with paraplegics, providing muscle stimulation to restore function.

The team has been advancing this technology for over ten years, with the first patient receiving an implant more than six years ago. French government grants support the research, and Hihi expressed interest in collaborating with stroke survivors for rehabilitation.

The implant's bio-compatible materials are rigorously tested prior to implantation. Instead of penetrating brain tissue, it rests on the surface, minimizing inflammation and fibrosis—a concept reminiscent of themes explored in William Gibson’s sci-fi short story, "Johnny Mnemonic."